Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
Aim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platel...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2008-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1525 |
_version_ | 1797857213451075584 |
---|---|
author | I. N. Medvedev T. A. Kumova |
author_facet | I. N. Medvedev T. A. Kumova |
author_sort | I. N. Medvedev |
collection | DOAJ |
description | Aim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platelets, antioxidant potential of blood serum and platelets, intravascular platelet activity were assessed. The data were analyzed using Student’s t test. Results: In individuals with AH and MS, eprosartan therapy reduced lipid peroxidation and optimized intravascular platelet activity. Long?term eprosartan treatment could strengthen this beneficial effect. Conclusion. To decrease body weight in persons with AH and MS, eprosartan should be combined with non?pharmaceutical methods. |
first_indexed | 2024-04-09T20:53:06Z |
format | Article |
id | doaj.art-4c34b509f8b8449dbef94e90707b26c7 |
institution | Directory Open Access Journal |
issn | 1560-4071 2618-7620 |
language | Russian |
last_indexed | 2024-04-09T20:53:06Z |
publishDate | 2008-02-01 |
publisher | «FIRMA «SILICEA» LLC |
record_format | Article |
series | Российский кардиологический журнал |
spelling | doaj.art-4c34b509f8b8449dbef94e90707b26c72023-03-29T21:23:15Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202008-02-010140421310Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndromeI. N. Medvedev0T. A. Kumova1Курский институт социального образования – филиал Российского государственного университетаКурский институт социального образования – филиал Российского государственного университетаAim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platelets, antioxidant potential of blood serum and platelets, intravascular platelet activity were assessed. The data were analyzed using Student’s t test. Results: In individuals with AH and MS, eprosartan therapy reduced lipid peroxidation and optimized intravascular platelet activity. Long?term eprosartan treatment could strengthen this beneficial effect. Conclusion. To decrease body weight in persons with AH and MS, eprosartan should be combined with non?pharmaceutical methods.https://russjcardiol.elpub.ru/jour/article/view/1525arterial hypertensionmetabolic syndromeplateletseprosartan |
spellingShingle | I. N. Medvedev T. A. Kumova Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome Российский кардиологический журнал arterial hypertension metabolic syndrome platelets eprosartan |
title | Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome |
title_full | Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome |
title_fullStr | Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome |
title_full_unstemmed | Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome |
title_short | Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome |
title_sort | eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome |
topic | arterial hypertension metabolic syndrome platelets eprosartan |
url | https://russjcardiol.elpub.ru/jour/article/view/1525 |
work_keys_str_mv | AT inmedvedev eprosartaneffectsonintravascularplateletactivityinpatientswitharterialhypertensionandmetabolicsyndrome AT takumova eprosartaneffectsonintravascularplateletactivityinpatientswitharterialhypertensionandmetabolicsyndrome |